Back to Journals » Hepatic Medicine: Evidence and Research
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (191)
- Volume 16, 2024 (6)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Journal Articles:
- 191 records -
Retrospective Database Analysis of Liver-Related Clinical Events in Adult and Pediatric Patients with Alpha-1 Antitrypsin Deficiency in the United States
Hagiwara M, Divino V, Munnangi S, Delegge M, Park S, Marins EG, Ren K, Strange C
Hepatic Medicine: Evidence and Research 2024, 16:55-64
Published Date: 24 July 2024
Construction and Application of Patient-Participated Health Care Guidance Plan for Patients with Decompensated Hepatitis B Cirrhosis
Su D, Zeng X, Tang Y, Wang W
Hepatic Medicine: Evidence and Research 2024, 16:45-54
Published Date: 4 June 2024
Advancing Hepatitis C Elimination in Africa: Insights from Egypt
Salomon I, Olivier S, Egide N
Hepatic Medicine: Evidence and Research 2024, 16:37-44
Published Date: 4 June 2024
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
Bu Y, Wen J, Wang F, Dong S, He L, Li Y, Liang J, Zhang H
Hepatic Medicine: Evidence and Research 2024, 16:31-36
Published Date: 20 April 2024
Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease
Blake MJ, Steer CJ
Hepatic Medicine: Evidence and Research 2024, 16:11-29
Published Date: 16 February 2024
The Free Triiodothyronine, Gamma-Glutamyl Transpeptidase and Spontaneous Bacterial Peritonitis Index: A Novel Model for Predicting 1-Year Mortality in Patients with HBV-Related Hepatic Encephalopathy
Lin L, Huang ZY, Liu K, Tong XC, Zhang ZX, Xue Y
Hepatic Medicine: Evidence and Research 2024, 16:1-9
Published Date: 22 January 2024
Medicinal Plants in Treating Hepatitis B Among Communities of Central Region of Ethiopia
Beykaso G, Teklehaymanot T, Mulu A, Berhe N, Alemayehu DH, Giday M
Hepatic Medicine: Evidence and Research 2023, 15:265-277
Published Date: 29 December 2023
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma
Wei Q, Hou YC, Mao FF, Feng JK, Wang X, Cheng SQ
Hepatic Medicine: Evidence and Research 2023, 15:249-264
Published Date: 27 December 2023
Epidemiology of Hepatitis B in Saudi Arabia from 2006 to 2021
Alghamdi IG, Alghamdi RM, Alghamdi MS, Alghamdi AM, Alghamdi MI, Alghamdi ZI, Alghamdi KS
Hepatic Medicine: Evidence and Research 2023, 15:233-247
Published Date: 21 December 2023
Analysis of SARS-CoV-2 Variant-Specific Serum Antibody Post-Vaccination Utilizing Immortalized Human Hepatocyte-Like Cells (HLC) to Assess Development of Immunity
Collins DP, Steer CJ
Hepatic Medicine: Evidence and Research 2023, 15:221-231
Published Date: 5 December 2023
COVID-19 and the Liver: A Complex and Evolving Picture
Taylor-Robinson SD, Morgan MY
Hepatic Medicine: Evidence and Research 2023, 15:209-220
Published Date: 7 November 2023
Confounders of Serum Phosphatidylethanol: Role of Red Blood Cell Turnover and Cirrhosis
Bartel M, Hofmann V, Wang S, Mueller J, Sundermann TR, Mueller S
Hepatic Medicine: Evidence and Research 2023, 15:195-208
Published Date: 1 November 2023
Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?
John N, Ibrahim B, Ebaid M, Saab S
Hepatic Medicine: Evidence and Research 2023, 15:185-193
Published Date: 12 October 2023
The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease
Qiao C, Gu C, Wen S, He Y, Yang S, Feng X, Zeng Y
Hepatic Medicine: Evidence and Research 2023, 15:165-183
Published Date: 6 October 2023
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention
Lim JK, Njei B
Hepatic Medicine: Evidence and Research 2023, 15:151-164
Published Date: 4 October 2023
The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era
Manikat R, Ahmed A, Kim D
Hepatic Medicine: Evidence and Research 2023, 15:141-149
Published Date: 29 September 2023
The Burden of Inappropriate Prescriptions and Predictors for Hospitalized Patients with Liver Cirrhosis in Ethiopia
Zeleke TK, Bazezew ZA, Abebe RB
Hepatic Medicine: Evidence and Research 2023, 15:129-140
Published Date: 25 September 2023
Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
Ait Ahmed Y, Lafdil F, Tacke F
Hepatic Medicine: Evidence and Research 2023, 15:113-127
Published Date: 21 September 2023
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
Bartoli A, Cursaro C, Seferi H, Andreone P
Hepatic Medicine: Evidence and Research 2023, 15:93-112
Published Date: 1 August 2023
Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case–Control Study
Weldebrhan D, Berhe H, Tesfay Y
Hepatic Medicine: Evidence and Research 2023, 15:79-91
Published Date: 19 July 2023
Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
Sohal A, Kowdley KV
Hepatic Medicine: Evidence and Research 2023, 15:63-77
Published Date: 8 June 2023
The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content
Atzori S, Pasha Y, Maurice JB, Taylor-Robinson SD, Campbell L, Lim AKP
Hepatic Medicine: Evidence and Research 2023, 15:51-61
Published Date: 9 June 2023
Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study
Al-Dholae MHH, Salah MK, Al-Ashmali OY, Al Mokdad ASM, Al-Madwami MA
Hepatic Medicine: Evidence and Research 2023, 15:43-50
Published Date: 28 April 2023
Mucinous Cystic Neoplasms of the Liver: Epidemiology, Diagnosis, and Management
Hutchens JA, Lopez KJ, Ceppa EP
Hepatic Medicine: Evidence and Research 2023, 15:33-41
Published Date: 29 March 2023
COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis
Sarkis Y, Saleem N, Vuppalanchi R, Gromski M
Hepatic Medicine: Evidence and Research 2023, 15:27-32
Published Date: 28 March 2023
Factors Associated with in-Hospital Mortality in Malagasy Patients with Acute Decompensation of Liver Cirrhosis: A Retrospective Cohort
Razafindrazoto CI, Randriamifidy NH, Ralaizanaka BM, Andrianoelison JT, Ravelomanantsoa HT, Rakotomaharo M, Hasina Laingonirina DH, Maherison S, Rakotomalala JA, Rasolonjatovo AS, Rakotozafindrabe ALR, Rabenjanahary TH, Razafimahefa SH, Ramanampamonjy RM
Hepatic Medicine: Evidence and Research 2023, 15:21-26
Published Date: 12 March 2023
Medicinal Plants Used for the Management of Hepatitis Over the Past 15 Years in Ethiopia: A Systematic Review
Aschale Y, Tegegne BA, Yihunie W
Hepatic Medicine: Evidence and Research 2023, 15:11-19
Published Date: 9 March 2023
COVID-19-Associated Liver Injury
Gildea DT, Woo SM, O'Connor CE, Rangnekar AS
Hepatic Medicine: Evidence and Research 2023, 15:1-9
Published Date: 21 February 2023
Perspectives on Sarcopenia as a Predictor for Outcomes in Pediatric Patients with Chronic Liver Disease
Chen C, Ayers M, Squires JH, Squires JE
Hepatic Medicine: Evidence and Research 2022, 14:173-183
Published Date: 26 October 2022
Prevalence and Factors Associated with Hepatitis B Infection Among Outpatient Adults in South-Western Uganda
Rugaatwa Ndibarema E, Olum R, Ayebare D, Kabakyenga J
Hepatic Medicine: Evidence and Research 2022, 14:163-172
Published Date: 19 October 2022
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
Norcia LF, Watanabe EM, Hamamoto Filho PT, Hasimoto CN, Pelafsky L, de Oliveira WK, Sassaki LY
Hepatic Medicine: Evidence and Research 2022, 14:135-161
Published Date: 29 September 2022
Histopathological Evaluation of Ethanolic Leaf Extract of Lippia adoensis on Liver, Kidney, and Biochemical Parameters in Swiss Albino Mice
Boye AT, Ekanem PE, Hailu TB, Hordofa ID, Asfaw MS
Hepatic Medicine: Evidence and Research 2022, 14:123-133
Published Date: 20 September 2022
Undiagnosed Seroprevalence of Hepatitis B and C Virus Infections in the Community of Wolaita Zone, Southern Ethiopia
Kumalo A, Teklu T, Demisse T, Anjulo A
Hepatic Medicine: Evidence and Research 2022, 14:111-122
Published Date: 9 August 2022
Clinical, Laboratory and Bacterial Profile of Spontaneous Bacterial Peritonitis in Vietnamese Patients with Liver Cirrhosis
Nguyen LC, Lo TTB, La HD, Doan HTN, Le NT
Hepatic Medicine: Evidence and Research 2022, 14:101-109
Published Date: 30 July 2022
Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
Broquetas T, Carrión JA
Hepatic Medicine: Evidence and Research 2022, 14:87-100
Published Date: 29 July 2022
Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case–Control Study
Rakotomalala JA, Razafindrazoto CI, Randriamifidy NH, Ralaizanaka BM, Maherison S, Hasina Laingonirina DH, Rakotomaharo M, Rasolonjatovo AS, Rakotovao MA, Rakotozafindrabe ALR, Rabenjanahary TH, Fanantenantsoa R, Razafimahefa SH, Ramanampamonjy RM
Hepatic Medicine: Evidence and Research 2022, 14:79-85
Published Date: 18 May 2022
Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia
Tassachew Y, Abebe T, Belyhun Y, Teffera T, Shewaye AB, Desalegn H, Andualem H, Kinfu A, Mulu A, Mihret A, Howe R, Aseffa A
Hepatic Medicine: Evidence and Research 2022, 14:67-77
Published Date: 13 May 2022
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
Yoshitani H, Ito J, Kozono H
Hepatic Medicine: Evidence and Research 2022, 14:37-66
Published Date: 2 May 2022
Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation
McCain JD, Chascsa DM
Hepatic Medicine: Evidence and Research 2022, 14:27-36
Published Date: 29 April 2022
Viral Hepatitis - The Road Traveled and the Journey Remaining
Malik GF, Zakaria N, Majeed MI, Ismail FW
Hepatic Medicine: Evidence and Research 2022, 14:13-26
Published Date: 9 March 2022
Evaluation of the Effect of Hydromethanolic Seed Extract of Lepidium sativum L. (Fetto) on Deep-fried Palm Oil Diet Induced Nonalcoholic Fatty Liver Disease on Male Swiss Albino Mice
Tofik Ahmed E, Zawdie B, Nair SKP, Welde M, Mateos Husen T
Hepatic Medicine: Evidence and Research 2022, 14:1-12
Published Date: 22 February 2022
Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
Barsouk A, Thandra KC, Saginala K, Rawla P
Hepatic Medicine: Evidence and Research 2021, 13:145-146
Published Date: 30 December 2021
Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
Owen ML, Beal EW
Hepatic Medicine: Evidence and Research 2021, 13:137-143
Published Date: 22 December 2021
The Prognostic Values of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-Hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study [Erratum]
Mahassadi AK, Anzouan-Kacou Kissi H, Attia AK
Hepatic Medicine: Evidence and Research 2021, 13:135-136
Published Date: 19 December 2021
The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study
Mahassadi AK, Anzouan-Kacou Kissi H, Attia AK
Hepatic Medicine: Evidence and Research 2021, 13:123-134
Published Date: 8 December 2021
Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Letter]
Ghanghro L
Hepatic Medicine: Evidence and Research 2021, 13:121-122
Published Date: 7 December 2021
Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
Ayelign M, Aynalem M, Berhane N
Hepatic Medicine: Evidence and Research 2021, 13:113-120
Published Date: 11 November 2021
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
Gioia S, Riggio O, Nardelli S, d'Amati G, Ridola L
Hepatic Medicine: Evidence and Research 2021, 13:105-111
Published Date: 3 November 2021
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
Serifis N, Tsilimigras DI, Cloonan DJ, Pawlik TM
Hepatic Medicine: Evidence and Research 2021, 13:93-104
Published Date: 2 November 2021
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
Sivakumar T, Kowdley KV
Hepatic Medicine: Evidence and Research 2021, 13:83-92
Published Date: 28 August 2021